ZiganshinaLEJørgensenKJ, The first ever cochrane event in Russia and Russian speaking countries – Cochrane Russia launch – evidence-based medicine: Achievements and Barriers (QiQUM 2015) International Conference, Kazan, Russia, December 7–8, 2015. International Journal of Risk & Safety in Medicine. 2016;28(4):221–226. https://doi.org/10.3233/JRS-170732
2.
YudinaEVZiganshinaLE. Russian translations for cochrane. Int J Risk Saf Med2015; 27(1_suppl): S112–S113. https://doi.org/10.3233/JRS-150713
3.
ZiganshinaLEMenkesDBHerxheimerA. Quality information for quality use of medicines; 2nd international conference, kazan, 15–16 October 2010. Int J Risk Saf Med2011; 23(3): 187–192. https://doi.org/10.3233/JRS-2011-0535
4.
International conference “Evidence-Based Medicine: achievements and Barriers” (QiQUM 2015) 7-8 December 2015. Int J Risk Saf Med2015; 27(3):167–168. https://doi.org/10.3233/JRS-150658
5.
CastellanaEBudauPMChiappettaMR. Pharmacovigilance: overview of Italian and European regulations, tools, and perspectives. Int J Risk Saf Med2025; 36(4): 147–155. https://doi.org/10.1177/09246479251366836
6.
Haliuchenka V, Zhyltsou I, Skreblo Y. Evidence-based medicine as an educational discipline-experience of implementation in undergraduates and doctors training. Int J Risk Saf Med. Online ahead of print 10 November 2025. https://doi.org/10.1177/09246479251390453
7.
Mao J, Yamakawa M, Takeya Y. Drug-related adverse events in people with dementia – Statistical data from the FDA adverse event reporting system. Int J Risk Saf Med 2025; 1-8. https://doi/10.1177/09246479251385395
8.
Mariana N, Gayatri A, Widyahening IS. Adverse drug reactions to the nine-month all-oral and 18-month regimens for multidrug-resistant tuberculosis in Indonesia. Int J Risk Saf Med 2025. https://doi.org/10.1177/092464792513705